[68Ga]-NeoBOMB1 Imaging in Patients With Malignancies Known to Overexpress Gastrin Releasing Peptide Receptor (GRPR)

NCT03724253 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

19

Enrollment

INDUSTRY

Sponsor class

Stopped Recruitment was stopped before the target sample size was achieved.

Conditions

Breast Cancer
Prostate Cancer
Colorectal Cancer
Non Small Cell Lung Cancer
Small Cell Lung Cancer

Interventions

DRUG: [68Ga]-NeoBOMB1

Sponsor

Advanced Accelerator Applications